Active Not RecruitingNot applicableNCT02732834
Official study title

Clinician-Patient Communication in Lung Cancer Care

Study summary

The purpose of this study is to better understand communication between patients with lung cancer and their clinicians. The investigators are also interested in patient's perceptions of the quality of communication with his/her clinician and how these perceptions may impact patient outcomes. The clinician participating in this study and has given us permission to approach his/her eligible patients for study participation.

Ask AI to explain this study
Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedQuestionnaire and Patient Interview

Plus 6 other study approaches.

Who it may be forLung Cancer

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Feb 5, 2026 · Source: ClinicalTrials.gov

Is enrollment open?Active Not Recruiting

The study is underway but is not accepting new participants.

What kind of study?Not applicable

Observational

Where is it offered?7 U.S. locations

Locations may change over time.

Who runs it?Memorial Sloan Kettering Cancer Center

Study sponsor

01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
Memorial Sloan Kettering Cancer Center
Interventions being studied
Behavioral: Questionnaire; Behavioral: Patient Interview; Behavioral: Audio recordings of clinical consultations; Behavioral: Questionnaire; Behavioral: 2-hour empathic communication skills training; Behavioral: Standardized Patient Assessments; Behavioral: Training evaluation; Behavioral: Patient recruitment
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • Patients with confirmed lung cancer diagnosis or mass suspicious of lung cancer as per clinician report and/or EMR
  • Lung cancer diagnosis or suspicious mass as per clinician report/EMR within 0-6 months of consent or within no more than three visits to participating clinician
  • Participating clinician approves his/her patient's participation in this study per clinician report.
  • Former (at least 100 cigarettes in lifetime and quit more than 30 days prior to enrollment) or current smoker (lifetime smoker who reports cigarette smoking within the past 30 days) as per self report or EMR;
  • English fluency (determined through EMR or clinician report), as we do not have the resources to translate the consultations from other languages or the surveys to other languages;
  • Patients must be 18 years old or older Clinician Inclusion Criteria:
  • An MSK attending physician (radiologists, medical oncologists, and surgeons), Nurse Practitioner (NP), Physician Assistant (PA), Fellow, Resident or Clinical Nurse Specialist (CNS) or Clinical Nurse (RN) who is a member of the Thoracic Disease Management Team or Pulmonary Service currently treating thoracic patients at MSK as per self report
  • Clinical has individual clinic consultations to discuss adult health assessment and/or smoking history with the target patient population: English-speaking, at least 18 years of age, has a suspicious lung mass or confirmed diagnosis, is a former/current smoker, has had no more than 3 visits with clinician or had diagnosis in past 6 months as per self-report.
Reasons someone may not be able to joinExclusion criteria

Clinician

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Memorial Sloan Kettering Basking Ridge (Consent and follow-up only)Basking Ridge, New Jersey
  • Memorial Sloan Kettering Monmouth (Consent and follow-up only)Middletown, New Jersey
  • Memorial Sloan Kettering Bergen (Consent and follow-up only)Montvale, New Jersey
  • Memorial Sloan Kettering Commack (Consent and follow-up only)Commack, New York
  • Memorial Sloan Kettering Westchester (Consent and follow-up only)Harrison, New York
  • Memorial Sloan Kettering Cancer CenterNew York, New York
  • Memorial Sloan Kettering Nassau (Consent and Follow-Up only)Uniondale, New York

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Feb 5, 2026. Always confirm current availability with the study team.

View original record ↗